European Scrutiny Committee Contents


6 Intellectual Property

(31064)

13706/09

--

Draft Revised Council Regulation on the Community patent

Legal baseArt. 118 TfEU; ordinary legislative procedure.
Deposited in Parliament29 October 2009
DepartmentBusiness, Innovation and Skills
Basis of considerationEM of 19 November 2009
Previous Committee ReportNone
To be discussed in Council4 December 09
Committee's assessmentLegally and Politically important
Committee's decisionCleared

Background

6.1 In contrast to the existing Community Trade Mark and Community design regimes, there is at present no single, centrally enforceable, European Union-wide patent. Nor is there any system of automatic mutual recognition. As a general rule, a patent granted for any one state in the EU is only valid for the territory of that state. However, the European Patent Office (EPO) provides a legal framework for the granting of 'European patents', which allows it to grant patents for up to 36 European states via a single, harmonized procedure. A single patent application, in one language, may be filed at the European Patent Office at Munich, at its branches at The Hague or Berlin or at a national patent office of a Contracting State, if the national law of the State so permits. However, after grant, a European patent is not a unitary right, but a group of essentially independent nationally-enforceable, nationally-revocable patents. The applicant chooses which, and how many, of the 36 states he wishes to have patents for. 'European patents' require translation into the respective language of designated each state, as well as separate renewal and litigation procedures. The EPO is not an EU body and was established in 1973 by inter-governmental agreement.

6.2 In March 2000 the Lisbon Agenda identified a need for a unitary patent which provides unified patent protection across the entire EU. The patent would create unitary Community rights and was referred to as a Community patent to distinguish it from existing European patents. Community patents would also be granted by the EPO.

6.3 Previous discussions with a view to adoption of a Regulation for a Community patent were suspended in 2004, mainly due to disagreement on patent languages and translations. Our predecessor Committee did not regard this and other related residual problems as a major issue for the United Kingdom and cleared the original and all subsequent revised texts of the proposal from scrutiny in 2003. It also welcomed and cleared the Commission's later discussion document "Enhancing the Patent System in Europe" (8302/07) in 2007. The Commission Communication revived discussions on the introduction of a Community Patent.

The Document

6.4 The previous text to have cleared scrutiny was the revised Greek Presidency text of 16 April 2003 (reference 8539/03). This text has now been replaced by a further revised proposal prepared by the Swedish Presidency. The proposed Community Patent would create a single Community-wide Patent conferring simultaneous, unitary rights in all Member States and, if declared invalid, would equally be invalidated in all Member States. The proposed Community Patent would, as envisaged under the Lisbon Agenda, operate alongside the existing national and EPO patent systems and offer an alternative route for patent protection in Europe.

6.5 The numbering of the articles in the revised proposal corresponds to that in previous versions of the Regulation, which means that where Articles have been removed there will be gaps in the numbering.

6.6 Article 1 establishes that all patents granted by the EPO which have effect throughout the Community shall be Community patents. Article 2 makes clear that Community patents can only be granted, transferred, declared invalid or lapse in respect of the whole of the Community.

6.7 Articles 4 to 6 specify who can apply for and own a Community patent.

6.8 Articles 7 to 13a set out the effects of a Community patent. Articles 7 and 8 allow the proprietor of the patent to prevent all third parties from using it directly or indirectly without his consent. Article 9 describes certain acts which do not infringe the rights described in Articles 7 and 8. These include acts done privately for non-commercial purposes, experimental purposes, and those in accordance with specified EC Directives. Article 9a allows for national governments to make non-commercial use of Community patents in situations of essential defence or national security. Article 10 establishes that Community patent rights are exhausted for products placed on the market in the Community by the patent owner or with his consent. Article 11 provides that compensation may be claimed from third parties who have made use of an invention protected by a Community patent between the publication of the patent application and the grant of the patent. Article 12 establishes that a person who made use of an invention in good faith prior to an application for a patent may continue that use. Article 13 establishes that in the case of a patent for a process an infringing product shall, in the absence of proof to the contrary, be deemed to have been obtained by the patented process. Article 13a allows conversion of a Community patent application into a European patent application, on request, at any time before grant of the patent.

6.9 Articles 14 to 24 concern the treatment of the Community patent as a piece of property, such as transfer, licensing and similar transactions. Article 20 allows a patent proprietor to pay reduced renewal fees in return for allowing any person to use the patented invention as a licensee, in return for adequate compensation, such licenses are called licenses of right. Article 21 and 22 allow the European and Community Patent Court (ECPC) to grant compulsory licences, that is licenses without the consent of the proprietor of a patent. These may be granted in times of crisis or to avoid abuses of patent rights, when a patent is not being exploited or when it prevents the exploitation of another patented invention. Member States are not to be permitted to grant licences of right or compulsory licences in respect of Community patents.

6.10 Articles 25 to 27a cover the renewal, surrender, lapse and re-establishment of the Community patent. The maximum duration of the Community patent is set at 20 years, as with national and European patents.

6.11 Articles 28 to 29a deal with the grounds for and effects of a Community patent being declared invalid, and the request for limitation of the patent by amendment of the claims. The grounds for invalidity include where the subject matter of the patent was not patentable according to the European Patent Convention, for example if the new invention is not new or inventive.

6.12 Article 54 prohibits the simultaneous protection of the same invention by both Community patent and national patent.

6.13 Articles 56 to 63 contain the final provisions of the Regulation. Article 56 requires the EPO to keep a register of Community patents which must be available for public inspection. Article 57 requires the EPO to publish a bulletin containing entries made in the Register of Community patents. Article 62 requires the Commission to publish a report on the implementation of the Regulation every five years from its entry into force. Article 63 governs the entry into force of the Regulation, which shall be on the sixtieth day following its publication in the Official Journal of the European Communities.

6.14 The latest text of the proposal also contains a number of amendments designed to address those concerns which led to the suspension of negotiations in 2004. Subparagraph (b.1) of Article 9 has been amended to include specific reference to Directives 2001/82/EC and 2001/83/EC, which provide exemptions to patent infringement during pharmaceutical trials and testing which is necessary for regulatory approval. Similarly, subparagraph (j) has been added to provide for Directive 98/44/EC, which addresses the patentability of biotechnological inventions. These amendments reflect the implementation of these Directives into national patent law in recent years.

6.15 Articles 24a — 24b have been deleted. These Articles previously governed the translation of the Community patent. They stated that, on grant of a Community patent, translations of the patent claims into all official languages of the Community must be submitted, unless a Member State agreed to dispense with a translation into its language. The proposal for translation into all EU official languages (then 12, now 23), was one of the main reasons that industry rejected the deal presented in 2003 and why those negotiations stalled. During the French Presidency in 2008, it was proposed that the number of translations should be limited further. Translation of the patent claims would be required in only the three official languages of the European Patent Convention (English, French and German), with machine translations being used for other languages if necessary. Machine translations would enable wide public awareness of the content of patents, but would not be legally binding. In order to expedite agreement of the Community patent Regulation, these Articles have now been removed from the current Regulation text, and it is proposed that whatever language regime is agreed will instead be provided for amendments to the European Patent Convention, or a separate legal instrument.

6.16 Articles 30 — 53i have been deleted. These Articles previously provided for litigation of Community patents and conferred exclusive jurisdiction to the ECJ. In response to the Commission's communication "Enhancing the Patent System in Europe", current proposals are moving towards a more limited role for the ECJ restricted to ensuring the primacy of EC law, with exclusive jurisdiction over Community patents being conferred to a proposed separate ECPC, to be established by international treaty. This court would be able to hear litigation on both Community and European patents so as to provide consistent decisions across Europe.

6.17 The Community Patent Regulation would not enter into force, until the ECPC has been established, to ensure that when the first Community patents are granted there will already be a specialist court available to deal with disputes. The ECJ has been asked for its opinion on whether the establishment of the court is compatible with the EC Treaty, and is expected to deliver its opinion in 2010. Until it has done so, detailed discussion of the ECPC treaty has been put on hold.

6.18 Article 60 has been deleted. This Article previously related to Community patent fees and in particular the distribution of renewal fees. There are still some outstanding issues to be resolved regarding these provisions, and so, again, these Articles have been removed from the current Regulation text, and it is proposed that renewal fees may instead be provided for in amendments to the European Patent Convention.

6.19 Applications for Community patents will be administered by the EPO. The Regulation will not affect or replace the other patent regimes and processes administered by the EPO.

The Government's View

6.20 In his Explanatory Memorandum of 18 November 2009 the Minister of State at the Department for Business, Innovation and Skills (David Lammy) reaffirms the Government's previous support for the proposal and summarises the Government's position with reference to a number of central issues:

Translations

"Inability to agree on the languages of the Community patent has been a longstanding barrier to overall agreement. Translation of a whole patent into a single language averages over 1000 Euros, and translation only of a patent's claims (which describe its legal scope) averages over 250 Euros. As there are now 23 EU official languages, even translations limited to a patent's claims, covering all EU official languages, would be very expensive. This would have been the consequence of the deal presented in 2003, and rejected in 2004, which was roundly opposed by industry.

"The proposal currently under discussion, but now removed from the Regulation for later agreement in a separate instrument, is for patents to be published in one of three languages — English, French and German — and for a patent's claims to be published in all three of these languages. Machine translations of the full patent would be available in all 23 EU languages, and a special translation system with a focus on technical language is being constructed for this purpose. This approach aims to balance the need for public information, with the need for low costs and legal certainty given by a reduced language system. The UK Government support this, due to the significant cost savings over current translation requirements for European patents, though could support other efficient language regimes. Many other Member States could also support this.

"However, a number of Member States argue that the current language regime is discriminatory and favours a small number of languages. They also believe that this will disadvantage the general public in those states whose languages are not represented, as they will not be able to understand what is covered by a Community patent.

Court jurisdiction

"The UK Government support the role of the ECJ being limited to ensuring primacy of EC law. Initial discussions on the ECPC international treaty have raised a number of issues on the organisation and operation of the court. There are still some issues yet to resolve, and although these do not have a direct impact on the Community patent Regulation, they will necessarily have an impact on the litigation of Community patents granted under the Regulation.

Fees

"One of the UK Government's main concerns over the Community patent was that the overall fees (application and renewal) received by the EPO cover their costs in delivering Community patents. Current fee proposals are to be provided for in amendments to the European Patent Convention, and Council Conclusions (also tabled for agreement at the Competitiveness Council on 4 December 2009) include that the overall fee regime will sufficiently cover the EPO's costs. Whilst application fees are expected to be similar to those for a European patent, the Council Conclusions state that the level of renewal fees should be fixed with the aim of facilitating innovation and fostering the competitiveness of European business. It should also reflect the size of the market covered by the Community patent and be similar to the level of the renewal fees for what is deemed to be an average European Patent. Although the Council Conclusions do not define an "average European patent", it is generally taken to mean one which covers seven European states. Therefore, for obtaining and renewing patent protection in more than seven EU states, a Community patent should cost less, in terms of fees, than a European patent. Current renewal fee distribution proposals include the EPO receiving 50%, with the remaining 50% being distributed among the Member States. Although the distribution of these fees is yet to be discussed, it is expected that the UK's share will be less than that for an average European patent. However, until the exact distribution of the renewal fees is discussed it is not possible to ascertain its impact on revenue.

Licensing

"The possibility of the Community court ruling on compulsory licences and licences of right (Articles 20-22) rather than the Commission was specifically sought by major representative bodies (Chartered Institute of Patent Agents; Trade Marks, Designs and Patents Federation; UNICE; Association of the British Pharmaceutical Industry). Note that these provisions of the Regulation need to be without prejudice to Member States' and the Commission's powers under EC Competition law.

Competence

"Although the Government is broadly supportive of the Regulation, we would prefer that all other aspects of the proposed European patent reform (i.e. the ECPC and any necessary amendments to the European Patent Convention) are agreed at the same time as the Regulation. It may be perceived that there is a risk that agreement on the Regulation at this stage could be used to support arguments to the effect that agreement is to confer exclusive competence on the Community."

6.21 The Minister also informs us that the proposal is scheduled for discussion and timetabled for agreement of a general approach at the 4 December 2009 Competitiveness Council. If agreement is not reached in December then the Spanish and Belgian Presidencies of 2010 are expected to continue discussions on the Regulation.

Conclusion

6.22 We thank the Minister for this detailed summary and comments on the proposal for the creation of a Community Patent. When our predecessor committee cleared the previous text of the proposal, it had no outstanding questions or residual concerns. As none of the proposed amendments critically affects the substance of the proposed measure which, moreover, will not replace existing patent regimes in Member States but is designed to offer a unitary Community regime as an alternative route for patent protection, we see no reason to revise or rethink the position of our predecessor committee. Accordingly, we clear the proposal from scrutiny.





 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2009
Prepared 2 December 2009